ID: ALA4785490

Max Phase: Preclinical

Molecular Formula: C30H30BrNO6S

Molecular Weight: 612.54

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1C[C@]23C=C(Sc4ccc(Br)cc4)C(=O)[C@@](C)(CCC(=O)Nc4c(O)ccc(C(=O)O)c4O)[C@@H]2C[C@H]1CC3

Standard InChI:  InChI=1S/C30H30BrNO6S/c1-16-14-30-12-9-17(16)13-23(30)29(2,27(36)22(15-30)39-19-5-3-18(31)4-6-19)11-10-24(34)32-25-21(33)8-7-20(26(25)35)28(37)38/h3-8,15,17,23,33,35H,1,9-14H2,2H3,(H,32,34)(H,37,38)/t17-,23+,29+,30-/m1/s1

Standard InChI Key:  XEVQJZCQCXRTCV-BUMVFUDHSA-N

Associated Targets(non-human)

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

3-oxoacyl-[acyl-carrier-protein] synthase 2 80 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 612.54Molecular Weight (Monoisotopic): 611.0977AlogP: 6.91#Rotatable Bonds: 7
Polar Surface Area: 123.93Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.96CX Basic pKa: CX LogP: 6.88CX LogD: 3.39
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.20Np Likeness Score: 1.24

References

1. Li Y,Weng X,Deng Y,Pan J,Zhu S,Wen Z,Yuan Y,Li S,Shen B,Duan Y,Huang Y.  (2021)  Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA.,  12  (3.0): [PMID:33738071] [10.1021/acsmedchemlett.0c00653]

Source